Nucleoside diphosphate kinase A, NDK A, NDP kinase A, Granzyme A-activated DNase, GAAD, Metastasis inhibition factor nm23, NM23-H1, Tumor metastatic process-associated protein, NME1, NDPKA, NM23
Product description
This gene (NME1) was identified because of its reduced
mRNA transcript levels in highly metastatic cells. Nucleoside
diphosphate kinase (NDK) exists as a hexamer composed of 'A'
(encoded by this gene) and 'B' (encoded by NME2) isoforms.
Mutations in this gene have been identified in aggressive
neuroblastomas. Two transcript variants encoding different isoforms
have been found for this gene. Co-transcription of this gene and
the neighboring downstream gene (NME2) generates
naturally-occurring transcripts (NME1-NME2), which encodes a fusion
protein comprised of sequence sharing identity with each individual
gene product.1) Boissan, M., et al. Cancer Res. 70(19):7710-7722(2010)
Immunogen
This NME1 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 29-57 amino acids from the Central region of human NME1.
Western blot analysis in A549 cell line and human placenta lysates (35ug/lane).
Application Notes
For WB starting dilution is: 1:1000:
Additional Information
Form
Liquid
Storage Instructions
Store at 4˚C for three months and -20˚C, stable for up to one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.